Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: The LITE Study

N. Aleksic, A. R. Folsom, M. Cushman, S. R. Heckbert, M. Y. Tsai, K. K. Wu

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Plasma thrombomodulin (soluble TM; sTM) is considered to be a marker of endothelial injury, but a recent report indicated that the relationship of sTM with thrombosis is complex. Venous thromboembolic events were identified in adults in two longitudinal cohort studies, the Atherosclerosis Risk in Communities Study and the Cardiovascular Health Study, totaling 21 690 participants. After 8 years of followup, sTM was measured in baseline plasma of 305 participants who developed venous thrombosis and 607 who did not. Thrombomodulin A455V genotype was determined in 302 cases and 626 controls. There was no difference in the prevalence of the three TM genotypes between cases and controls and no difference in age-adjusted mean values of sTM by genotype. There were no associations of age-adjusted sTM or TMA455V genotype with overall venous thromboembolism or with thrombosis in any subtype of venous thromboembolism.

Original languageEnglish (US)
Pages (from-to)88-94
Number of pages7
JournalJournal of Thrombosis and Haemostasis
Volume1
Issue number1
DOIs
StatePublished - Jan 2003

Keywords

  • Polymorphism
  • Thrombomodulin
  • Venous thromboembolism

Fingerprint

Dive into the research topics of 'Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: The LITE Study'. Together they form a unique fingerprint.

Cite this